Article Text

Download PDFPDF
Systemic administration of the chemokine macrophage inflammatory protein 1α exacerbates inflammatory bowel disease in a mouse model
  1. S L-F Pender1,*,
  2. V Chance1,*,
  3. C V Whiting2,
  4. M Buckley1,
  5. M Edwards3,
  6. R Pettipher3,
  7. T T MacDonald1
  1. 1Division of Infection, Inflammation, and Repair, University of Southampton School of Medicine, Southampton, UK
  2. 2Division of Veterinary Pathology, Infection, and Immunity, Department of Clinical Veterinary Science, University of Bristol, Langford, Avon, UK
  3. 3Oxagen Ltd, Milton Science Park, Oxfordshire, UK
  1. Correspondence to:
    Professor T T MacDonald
    Centre for Infectious Disease, ICMS, Barts and the London School of Medicine and Dentistry, Whitechapel, London E1 2AT, UK; t.t.macdonaldqmul.ac.uk

Abstract

Introduction: Exacerbations of inflammatory bowel disease are thought to be related to concurrent infections. As infections are associated with elevated local and serum concentrations of chemokines, we have determined whether systemic administration of the CC chemokine macrophage inflammatory protein 1α (MIP-1α) exacerbates colitis in a mouse model.

Methods: Colitis was induced in Balb/c mice using trinitrobenzene sulfonic acid (TNBS). Starting four days later, animals received daily intraperitoneal injections of recombinant MIP-1α. On day 7, mice were killed and pieces of colon taken for immunohistology and polymerase chain reaction analysis. The direct effects of MIP-1α on mucosal T cells and fibroblasts in vitro were also investigated.

Results: Systemic administration of MIP-1α markedly enhanced colitis with mice developing large transmural ulcers filled with granulation tissue. Treatment resulted in increased numbers of CD4 cells infiltrating the colonic lamina propria, increased interferon γ (IFN-γ) levels, and increased transcripts for tumour necrosis factor α (TNF-α) and matrix metalloproteinase 3 (MMP3). Isolated lamina propria lymphocytes from mice with TNBS colitis contained increased numbers of IFN-γ and TNF-α transcripts when stimulated with MIP-1α in vitro. Colonic lamina propria fibroblasts also responded to MIP-1α with increased proliferation and decreased collagen 1 synthesis but fibroblast proliferation was not seen in vivo.

Conclusions: These experiments show that increasing serum concentrations of a chemokine, MIP-1α, exacerbates immune mediated colitis. The effect seems to be due to the ability of MIP-1α to boost Th1 responses in the gut wall. Our findings also suggest a potential pathway by which peripheral infections can exacerbate inflammatory bowel disease.

  • MIP-1α, macrophage inflammatory protein 1α
  • TNBS, trinitrobenzene sulfonic acid
  • TNF-α, tumour necrosis factor α
  • MMP3, matrix metalloproteinase 3
  • IBD, inflammatory bowel disease
  • IL, interleukin
  • PCR, polymerase chain reaction
  • LPL, lamina propria lymphocytes
  • FCS, fetal calf serum
  • TGF-β, transforming growth factor β
  • PBS, phosphate buffered saline
  • PBT, PBS/Tween 20
  • BSA, bovine serum albumin
  • colitis
  • chemokine
  • T cell
  • macrophage inflammatory protein 1α
  • inflammatory bowel disease

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • * Both of these authors provided data crucial to this publication and so joint first authorship is acknowledged.

  • Conflict of interest: None declared.